BioNexus Gene Lab (BGLC) Inventory (2018 - 2026)

BioNexus Gene Lab's Inventory history runs 9 years deep, the most recent figure standing at $667154.0 for Q1 2026.

• In Q1 2026, Inventory fell 43.42% year-over-year to $667154.0; the TTM figure through Mar 2026 stood at $667154.0 (down 43.42% YoY), while the FY2025 annual figure was $676703.0, down 51.27% from the prior year.
• Inventory came in at $667154.0 for Q1 2026 at BioNexus Gene Lab, down from $676703.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.6 million in Q1 2022 to a low of $667154.0 in Q1 2026.
• A 5-year average of $1.1 million and a median of $1.1 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory climbed 25.38% in 2024 and tumbled 51.27% in 2025, its largest moves.
• BioNexus Gene Lab's Inventory stood at $977807.0 in 2022, then increased by 16.36% to $1.1 million in 2023, then advanced by 22.05% to $1.4 million in 2024, then sank by 51.27% to $676703.0 in 2025, then dropped by 1.41% to $667154.0 in 2026.
• According to Business Quant data, Inventory over the past three periods registered $667154.0, $676703.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison